Real-time measurement of -infected erythrocyte cytoadhesion with a quartz crystal microbalance by unknown
Kömpf et al. Malar J  (2016) 15:317 
DOI 10.1186/s12936-016-1374-7
METHODOLOGY
Real-time measurement of Plasmodium 
falciparum-infected erythrocyte cytoadhesion 
with a quartz crystal microbalance
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Abstract 
Background: An important virulence mechanism of the malaria parasite Plasmodium falciparum is cytoadhesion, the 
binding of infected erythrocytes to endothelial cells in the second half of asexual blood stage development. Conven-
tional methods to investigate adhesion of infected erythrocytes are mostly performed under static conditions, many 
are based on manual or semi-automated read-outs and are, therefore, difficult to standardize. Quartz crystal micro-
balances (QCM) are sensitive to nanogram-scale changes in mass and biomechanical properties and are increasingly 
used in biomedical research. Here, the ability of QCM is explored to measure binding of P. falciparum-infected erythro-
cytes to two receptors: CD36 and chondroitin sulfate A (CSA) under flow conditions.
Methods: Binding of late stage P. falciparum parasites is measured in comparison to uninfected erythrocytes to 
CD36- and CSA-coated quartzes by QCM observing frequency shifts. CD36-expressing cell membrane fragments and 
CSA polysaccharide were coated via poly-l-lysine to the quartz. The method was validated by microscopic counting of 
attached parasites and of erythrocytes to the coated quartzes.
Results: Frequency shifts indicating binding of infected erythrocytes could be observed for both receptors CD36 and 
CSA. The frequency shifts seen for infected and uninfected erythrocytes were strongly correlated to the microscopi-
cally counted numbers of attached cells.
Conclusions: In this proof-of-concept experiment it is shown that QCM is a promising tool to measure binding 
kinetics and specificity of ligand-receptor interactions using viable, parasite-infected erythrocytes. The method can 
improve the understanding of the virulence of P. falciparum and might be used to cross-validate other methods.
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Background
Quartz crystal microbalances (QCM) are highly sensitive 
sensors that can reliably weigh material in the nanogram 
range and are highly sensitive to changes in biomechani-
cal properties of coupled biomaterial. They consist of a 
thin, usually round slice of crystalline quartz with a gold 
electrode on each side. Oscillating crystals are composed 
of α-Quartz (SiO2) that is known to be piezoelectric 
material, characterized by: (a) appearance of electrical 
potential when it is subjected to mechanical stress (pie-
zoelectric effect); and, (b) deformation of the material 
when it is subjected to electrical potential (inverse pie-
zoelectric effect). Due to the piezoelectric character the 
quartz is stimulated to oscillations when connected to 
AC voltage [1]. Material attaching to the quartz’s surface 
reduces the frequency. Thus, an increase in weight leads 
to an adequate decrease in frequency. In biosciences, 
mass-sensitive QCM are already well accepted, while 
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applications for clinical questions, in particular with 
whole blood samples, are novel and have not yet been 
exploited. Lately, this technology has been applied to the 
typing of blood groups, detection of bacteria, bacterial 
toxins, viruses, and measuring affinity of antibodies. Fur-
ther studies on adherent cell types have been performed 
but the measurement of whole cell interactions of pri-
marily non-adherent cells has not been addressed thor-
oughly [1–6].
Here a novel QCM-based assay is presented to evalu-
ate whole cell interactions by measuring cytoadhesion of 
erythrocytes infected with the malaria parasite Plasmo-
dium falciparum to endothelial cell receptors. Malaria 
is the most important parasitic infection and accounted 
for more than 200 million episodes and 438,000 deaths 
in 2015 [7]. The disease is caused as a result of the infec-
tion by protozoan parasites of the genus Plasmodium. 
Symptoms only occur during the blood stage of the infec-
tion when parasites multiply in red blood cells. Among 
five different species known to infect humans, P. falci-
parum causes the most severe form of the disease and is 
responsible for the vast majority of deaths. In contrast to 
the other species, P. falciparum-infected red blood cells 
(iRBCs) adhere to vascular endothelium of postcapillary 
venules (sequestration) and to non-infected erythrocytes 
(rosette formation) in the second half of their asexual 
replication, cycle via P. falciparum erythrocyte mem-
brane protein 1 (PfEMP1), which is expressed on the sur-
face of iRBCs [8, 9]. Through cytoadhesion the parasite 
avoids clearance by the spleen; this is an immune evasion 
mechanism that can lead to excessive parasite multiplica-
tion and may result in complications such as cerebral and 
placental malaria [10–13]. Important receptors involved 
in this process are CD36, ICAM1 in cerebral malaria and 
chondroitin sulfate A (CSA) in placental malaria [14–
16]. This work focuses on the binding of iRBC to CD36 
and CSA. CD36 is expected to be the main receptor of 
iRBC adhesion as nearly all laboratory isolates of P. fal-
ciparum, as well as clinical isolates from patients attach 
to this receptor [15–17]. CSA on the other hand, is well 
described to be the main receptor of parasite binding 
in placental malaria and parasites expressing the highly 
conserved PfEMP1 gene var2csa are known to bind to 
this polysaccharide [14, 18, 19]. Placental malaria can 
cause low birth weight of newborns, premature delivery, 
abortion, stillbirth, maternal anaemia, as well as infant 
and maternal morbidity and mortality [20, 21]. CSA is 
also present on other endothelial tissue where parasites 
might bind to it [22].
Different methods have been developed to measure 
PfEMP1-mediated cytoadhesion. Up until now most of 
the established cytoadhesion assays have been performed 
under static conditions [23–26], thus lacking shear stress 
which is assumed to be important for the parasites to get 
in contact with the appropriate receptors. However, flow-
based assays exist as well and some include static peri-
ods at the beginning of the measurement to allow settling 
of parasites, so that they are able to make contact with 
the immobilized receptors [27–32]. The disadvantage 
of some of these systems is that handling of the con-
structions is cumbersome; for example, the read-out is 
microscopy-based and therefore analysis of results is less 
standardized [33–36]. Hence, a real-time detection of 
cytoadhesion is not possible and an adequate evaluation 
of the experiments performed with these microscope-
based assays is time consuming and often reader biased. 
Another limiting aspect is that measuring of binding 
times and kinetics as well as discrimination between 
loosely adsorbed and truly adhered cells are very difficult.
The analysis of this complex interaction would benefit 
from other highly sensitive and reproducible methods 
based on a different technology for validation. Therefore, 
QCM is adapted in this proof-of-concept experiment for 
the analysis of PfEMP1-mediated iRBC binding to the cell 
surface of CD36-expressing melanoma cells as well as to 
CSA. It is the first time that QCM under flow conditions 
has been used with viable iRBCs and these experiments 
show the great potential of this approach for future stud-
ies in cell–cell as well as cell-receptor studies.
Methods
Parasite culture
The parasite strains FCR3-CD36 and FCR3-CSA were 
kindly provided by Artur Scherf, Institute Pasteur Paris, 
and were cultivated as previously described [37] in fresh 
group O+ erythrocytes at 5 % haematocrit in RPMI-1640 
supplemented with 2 mM l-glutamine, 50 µg/ml genta-
mycin, 25 mM HEPES, 0.5 % Albumax II, and 5 % AB+ 
human serum (complete medium). Culture flasks were 
aerated with 5  % carbon dioxide, 5  % oxygen and 90  % 
nitrogen. Specific binding phenotype of parasites was 
maintained by regular selection. For CD36 this was per-
formed by monthly panning of late-stage, infected eryth-
rocytes on C32-melanoma cells, at pH 6.8, as described 
elsewhere [38, 39]. To select parasites for specific bind-
ing to CSA, late blood stages were panned monthly on 
polystyrene six-well plates, coated with CSA from bovine 
trachea (Sigma) as previously described [40]. No nega-
tive selection of parasites was done and parasites were 
used for experiments after at least one round of selection. 
Prior to adhesion assays, cultures were synchronized by 
treatment with 5 % sorbitol and late stages were purified/
enriched by magnetic cell sorting (MACS) as described 
elsewhere [41].
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C32‑melanoma cell culture
C32-melanoma cells expressing large amounts of CD36 
were obtained from the American Type Culture Col-
lection (ATCC) and cultured at 5 % carbon dioxide and 
37  °C using DMEM supplemented with 50  µg/ml gen-
tamycin, 10  % FCS, 2  mM l-glutamine, and 1  % MEM 
non-essential amino acid solution (NEAA). Splitting 
of cells was performed when cultures reached 80–90  % 
confluence.
QCM sensors
The QCM sensors used in this work were AT-cut, 
10  MHz quartz crystals (8  mm in diameter, thickness 
of 166  μm (KVG Quartz Crystal Technology, Neckar-
bischofsheim, Germany) with a special gold electrode 
design developed by FKG.
Base coating of quartz surface
To successfully immobilize receptors to the quartz, a base 
coating with poly-l-lysine (PLL, Fluka 70–150  kDa) to 
untreated sensors was done by dropping 60 µl of 0.5 mg/
ml PLL in H2O to the quartz and subsequent drying 
under a stream of nitrogen [25]. For each experiment 
a new quartz was used as a complete cleaning of used 
quartzes was not possible.
Coating of CD36 to the quartz surface
CD36 belongs to the class B scavenger receptor proteins 
and is characterized by a special structure that is neces-
sary to ideally present the specific binding site to para-
sitized erythrocytes. Thus, to preserve this structure for 
CD36 coating, membranes or membrane fragments of 
C32 cells were prepared by homogenization of C32 cells 
with a potter on ice using a fractioning buffer consist-
ing of Tris/HCl (50  mM), NaCl (150  mM) and EDTA 
(1  mM). To separate the membrane fragments from 
nuclei and intact cells, the suspension was centrifuged at 
540×g (10 min, 4 °C). In a next step the supernatant was 
centrifuged at 2500×g (15 min, 4  °C) to remove further 
organelles. The last centrifugation step using an ultracen-
trifuge at 100,000×g (1 h, 4 °C) served to concentrate the 
membrane fragments. After removal of the supernatant 
the pellet was re-suspended in 400 µl fractioning buffer 
supplemented with 800 µl of a proteinase-inhibitor solu-
tion (Roche). Aliquots were stored at −20 °C. To achieve 
a coating as homogeneous as possible, membrane sus-
pensions were incubated with PBS-Tween-20 (0.1 %) for 
5 min. Immobilization on PLL-coated quartzes was done 
by dropping 60 µl of suspension to the quartz, and subse-
quent incubation for 10 min before unbound membranes 
were washed away with PBS. This was followed by fixa-
tion with 4 % paraformaldehyde in PBS on ice for 7 min 
and blocking with 2 % BSA in PBS (1 h, RT).
Coating of CSA to the quartz surface
To coat CSA to the quartz surface CSA (Sigma, 1 mg/ml 
in PBS) was immobilized ‘online’ to PLL. Following the 
insertion of the PLL-coated quartz to the QCM platform, 
the CSA solution was allowed to run over the quartz at a 
flow rate of 50 µl/min for 10 min to enable CSA to bind 
to the PLL-coated quartz. This was followed by a washing 
step with flow medium for 5 min at 100 µl/min.
To verify binding specificity for PLL basis coating, con-
trol human serum was added to the quartz outside of the 
platform before adding iRBCs (FCR3-CSA) without prior 
coating of CSA.
Verification of coating by immunofluorescence
Distribution of the receptors CD36 and CSA on the 
quartz were verified by an indirect immunofluorescence 
test (IFT). A separate sample was treated with second-
ary antibody only, to control for unspecific binding of 
the antibody. After coating, quartzes were fixed with 4 % 
paraformaldehyde in PBS on ice for 7  min, followed by 
blocking with 2 % BSA in PBS (1 h, RT).
The distribution of CD36 on the membrane of C32 cells 
was visualized by staining with a monoclonal mouse-
anti CD36 antibody (Abcam, 1:10 in PBS, 1 h, RT); and 
a sheep anti-mouse IgG F(ab′)2 fragment–FITC antibody 
(Sigma, 1:30 in PBS, 1  h, RT). For verification of CSA-
coating, quartzes were stained with a monoclonal mouse 
anti-CSA antibody (Sigma, 1:100 in PBS, 1 h, RT) and a 
FITC-labelled goat anti-mouse IgM antibody (Sigma, 
1:128, 1 h, RT).
Pictures of stained quartzes were taken by the digital 
camera Casio QV 5700 at the Axioskop 2MAT micro-
scope with 100× or 500× magnification. Overlay of pic-
tures was made with Adobe Photoshop 7.0.
Sensor platform and adhesion assay using QCM‑sensors
QCM-sensors can detect very low mass changes depos-
ited on the quartz by changes in resonance frequency. 
Frequency shifts due to adhesion processes to receptors 
were electronically recorded and analysed using a sensor 
platform called ‘Fidget Type 1’ [42, 43] (Fig. 1a). As two 
integrated QCM sensor channels exist, it is possible to 
simultaneously examine two samples (sample + control) 
under the same conditions. The platform is equipped 
with an automated flow-injection system and a Peltier 
element, which enables stable measurements at specific 
temperatures. Control measurements with human serum 
focusing on the PLL coating systems were performed 
at a later time point on the further developed and com-
mercially available beta version sensor platform qCell 
T [44] (Fig. 1b). The one channel platform qCell T pro-
vides dissipation measurements in addition to the fre-
quency curves. However, as dissipation curves do not 
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add substantial information to the results they are not 
presented here. The other functions and results obtained 
from the measurements are comparable to the old ver-
sion but stability, sensor handling and software have been 
essentially improved.
To ensure a sterile environment for measurements, 
the fluidic system was first disinfected by incubation 
with 1 % sodium hypochlorite for 10 min. After washing 
with sterile distilled water and a de-gassed flow medium 
(complete medium without sodium hydrogen carbonate 
and without human serum), sensors were inserted into 
the pre-heated platform (37  °C). Cell suspensions were 
diluted in flow medium and were transferred to the sen-
sor surface at a continuous flow rate (50 µl/min).
The optimal parameters for detection of adhesion 
processes to the receptors by iRBCs were achieved by 
systematically adapting measurement periods, cell con-
centrations and flow rates. Final experiments with CD36 
and CSA coated to PLL were performed with the opti-
mized closed fluidics system. The flow rate was adjusted 
to 50 µl/min to fill the fluidic system at the onset of the 
measurement with flow medium, and to pump the cell 
suspension over the sensor during the period of the 
whole measurement of cell adhesion. For the assays, 
1.5  ×  105 iRBCs/ml or RBCs/ml were diluted in flow 
medium and allowed to circulate and flow over the 
quartz at 50 µl/min for 2.5 h in a closed system. The inner 
diameter of the tubes used was 0.38  mm, resulting in a 
velocity of 73 mm/s for the used flow rate.
Verification of parasite adhesion by microscopy after QCM
After binding experiments, quartzes were removed, 
rinsed with flow medium and fixed with 4  % paraform-
aldehyde in PBS on ice for 7 min. To determine the stage 
and viability of iRBCs adherent to the sensor’s surface, 
samples were stained with the DNA-stain DAPI (Sigma, 
0.2 µg/ml, 5 min, RT). The mean number of bound iRBCs 
and RBCs of three visual fields, corresponding to a sur-
face of 22.1  ×  103 µm2, were determined by counting 
under a microscope (AxioImager, Zeiss, magnification 
500×).
Analysis
Frequency shifts were analysed using qCell T software. 
Median differences, the interquartile range as well as 
the single measurements are shown for frequency shifts 
and the subsequent microscopic count data of attached 
parasites to the quartz. Microscopic counts of attached 
infected and uninfected RBCs are correlated to frequency 
shifts by Spearmans rho for paired samples.
Results
Verification of CD36 coating of the quartz
Expression of CD36 on C32 melanoma cells was veri-
fied by fluorescence microscopy, after staining with an 
anti-CD36 antibody showing an intense staining evenly 
spread over the surface of the cell (Fig. 2a). Isolated cell 
membranes of melanoma cells were immobilized to the 
quartz surface via PLL and were stained with an anti-
CD36 antibody.
Images obtained by fluorescence microscopy show 
that an almost homogenous coating of the quartzes 
with CD36 could be achieved and that the CD36 anti-
body epitope was not destroyed by the processes of cell 
homogenization and the following differential centrifu-
gation (Fig.  2b). Minor differences in the dissemination 
of membranes to the sensors are caused by the nature 
of the biological medium in which CD36 is embedded. 
Fig. 1 QCM platform settings. a Fidget Type 1 and b qCell T. Thermo-controlled QCM platform (1) with fluidic measuring chambers for QCM-sen-
sors (2); peristaltic pumps (3); fluidic system with sample retainers (4); and, digital display (5)
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To preserve the complex structure of the CD36 protein, 
which belongs to class B scavenger receptor proteins, 
whole membranes of C32 melanoma cells are used. 
Whole cells could not be used as the layer on the sensor 
would be too thick and not rigid enough to determine 
interactions of the parasites with the coated sensors.
Verification of CSA coating via fluorescence microscopy
Coating of the quartz sensor with the receptor was con-
firmed by fluorescence microscopy (Fig. 2c). CSA immo-
bilized via PLL resulted in a homogenous and dense 
coating, illustrated by a strong, specific fluorescence sig-
nal. Coating of the sensor with CSA via PLL was addi-
tionally verified by on-line measurement in the platform. 
Injection of CSA led to a strong binding signal, which 
remained stable even after rinsing with high flow rates. 
Further incubation steps with different concentrations of 
bovine serum albumin (BSA) showed no additional bind-
ing events (Additional file  1). Thus, potential unspecific 
binding sites appear to be non-accessible.
Measurement of binding of Plasmodium falciparum iRBCs 
to receptors (CD36 and CSA) via QCM
In Fig. 3 an overview of the frequency shifts reflecting the 
mass change due to binding is shown in comparison to 
the microscopic counts of attached cells on the quartz. 
Parasites selected for CD36 binding (FCR3-CD36) 
adhered to CD36, reflected by a dampening of the sig-
nal (median frequency shift: −187  Hz, n =  6), whereas 
uninfected RBCs did not adhere to CD36 (median fre-
quency shift: −58.5  Hz, n =  4). This was also reflected 
by the microscopic cell count showing that a median 
of 36 iRBCs (n  =  6) attached to one visual field of the 
CD36-coated quartz, whereas only a median of 1.5 RBCs 
(n = 4) attached in the control experiment. The parasite 
strain selected for CSA binding (FCR3-CSA), specifically 
adhered to CSA immobilized to PLL, reflected by a 
dampening of the signal (median frequency shift: −9 Hz, 
n  =  5) after adding of parasites to the flow system. 
Uninfected RBCs did not bind (median frequency shift: 
133 Hz, n = 3). The results are reflected by the parasite 
counts performed after the experiments. When checking 
for attached parasites a median of 14 iRBCs (n = 5) could 
be counted in one visual field per quartz compared to a 
median of 0 attached RBCs (n = 3) on the control quartz. 
For the measurement of RBCs on the CSA-coated quartz, 
an increase in frequency occurred which is caused by a 
so-called ‘missing mass effect’ [45] leading to alterations 
in visco-elasticity.
Addition of late stage iRBCs to CD36 and late stage 
iRBCs to CSA led to a strong frequency shift compared to 
RBCs only. Representative frequency shifts obtained with 
infected and uninfected RBCs for a PLL-CD36-coated 
quartz are shown in Fig.  4a and for a PLL-CSA-coated 
quartz in Fig. 5a. Addition of infected or uninfected RBCs 
led to a short peak due to stopping of the pumps at the 
beginning of the measurement. Starting and stopping of 
the pumps led to differences in frequencies that restored 
when the normal flow rate (50 µl/min) was applied. After 
the short peak observed at the beginning of the meas-
urement, a decrease in frequency appeared caused by 
the cells arriving on the sensor’s surface. Thus, the sen-
sors detected the occurring mass change. The continuous 
flow of medium over the sensor rapidly spread the cells 
over the sensor and unbound cells were washed away 
leading to a balance of the frequency (≤5 min). The slow 
decrease of frequency over the 2.5 h was due to the con-
tinuous adhesion process of parasites during the experi-
ment. When adding RBCs, the signal stayed at the same 
level or even increased. The increase for RBCs seen in 
Fig. 5a was due to the visco-elastic behaviour of the PLL/
CSA layer, caused by the missing mass effect, mentioned 
Fig. 2 Quartz coating with CD36 using membranes of melanoma cells and CSA via PLL. a Overlay picture of a C32 melanoma cell stained for DNA 
(DAPI, blue) and CD36 (FITC, green) showing a homogenous spread of CD36 on the surface and the nucleus in the centre of the cell; b fluorescence 
picture of isolated and homogenized cell membranes of C32 melanoma cells immobilized to a PLL-coated quartz and stained with a CD36 antibody 
(FITC, green); c overlay picture of a quartz coated with PLL/CSA showing an even distribution of fluorescence signal, indicating a homogenous coat-
ing of CSA to the quartz. The quartz was stained with an anti-CSA antibody (FITC, green)
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above. Differences between the course of the two sig-
nals of CD36 and CSA are due to the differently coated 
quartzes; for CD36, whole cell membrane fragments were 
immobilized to the quartz surface whereas for CSA the 
quartz was coated with the polysaccharide alone. As it is 
assumed that iRBCs develop stronger adhesion to CD36 
than to CSA, different binding kinetics can be observed.
The number of attached cells was correlated with the 
observed frequency shift (rho  =  −0.55, p  =  0.017). 
Example images of one microscopic field are given in 
Fig.  4b, c for CD36 and iRBCs and RBCs, respectively, 
and in Fig. 5b, c for CSA and iRBCs and RBCs, respec-
tively. They show that iRBCs with FCR3-CD36 parasites 
attached to CD36-coated quartzes and that iRBCS with 
FCR3-CSA parasites attached to CSA-coated quartzes 
(Figs. 4b, 5b), in contrast to uninfected RBC (Figs. 4c, 5c), 
where only a very few cells attached.
PLL by itself is very sticky for any kind of cell and can 
therefore not be used without a receptor/analyte. PLL-
coated quartzes alone bound added cells very strongly 
and quickly (within minutes) (see Additional file  2 for 
RBCs). As a separate control experiment, human serum 
proteins were immobilized to PLL and as expected, fre-
quency shifts showed that iRBCs (FCR3-CSA) did not 
bind to human serum proteins [median frequency shift: 
46 Hz (n = 3), Additional file 3].
Discussion
Measuring with QCM allows real-time observation of 
cellular interactions by evaluating adhesion processes of 
intact P. falciparum-infected RBCs and their respective 
receptor. Here a novel method is presented to measure 
cell adhesion processes of iRBCs to two different recep-
tors under flow conditions. Binding is analysed of iRBCs 
to CD36, a receptor most P. falciparum isolates adhere 
to, and binding to CSA, the main receptor involved in 
placental malaria. Dampening of the signal showed that 
iRBCs bound with higher affinity to the receptor when 
compared to uninfected RBCs, corresponding with the 
results obtained by microscopic counting of attached 
Fig. 3 Overview of QCM experiments measuring attachment of cells to receptors by frequency shifts and subsequent microscopic count. Median, 
interquartile range and single measurements of frequency shifts measured by the QCM platform Fidget Type 1 (upper panel) and subsequent 
microscopic count of the number of attached cells per microscopic field (lower panel) for either P. falciparum iRBCs of FCR3-CSA strain (n = 5) and 
red blood cells (RBC, n = 3) added to CSA receptors (CSA), or for iRBCs of FCR3-CD36 strain (n = 6) and RBCs (n = 4) added to CD36 receptors. 
Results show that iRBCs (FCR3 parasites) bind to the respective receptor, reflected by a dampening of the frequency and a higher count data in the 
microscope whereas RBCs do not bind. CSA chondroitin sulfate A, PLL poly-l-lysin
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cells. Control experiments with human serum as unspe-
cific analyte showed that iRBCs did not bind to serum 
proteins coated to PLL. The observed increase in fre-
quency similar to the experiments of CD36 and RBCs 
is probably caused by a change of the visco-elasticity of 
the sensors surface called the missing mass effect [45]. 
Only by adding cells and medium to the sensor, could a 
conformation change of PLL be achieved so that a more 
rigid layer is present, influencing the sensor’s behaviour. 
However, a control experiment with PLL and human 
serum shows that frequency shifts obtained with the 
iRBCs using the PLL/CD36- or PLL/CSA-coated sen-
sors are due to specific interactions between the iRBCs 
and the receptors, and not to unspecific interactions with 
PLL. Parasite binding to CSA is a relevant model for pla-
cental malaria, and evaluation of inhibiting antibodies 
and vaccine candidates under flow conditions by QCM 
could complement existing methods. Further experi-
ments with the QCM should be performed to explore the 
potential of this methodology in studying malaria para-
sites in more depth. Future experiments should include 
different parasite strains, including freshly isolated clini-
cal isolates from the relevant organ (e.g., placenta), in 
addition experiments with inhibiting antibodies and 
possible blocking proteins should be performed to evalu-
ate the potential of the methodology. One weakness of 
the system is that coating of a sugar as done with CSA 
might not represent the three-dimensional structure 
found in nature, a problem circumvented by coating of 
membranes displaying CD36 on their surface. Despite 
this however, this methodology has the weakness that 
one cannot fully control correct positioning of the mem-
branes, and some might even be attached upside down. 
So far QCM technology has been applied only to analyse 
molecules in malaria research but not for studying the 
whole parasite. One group established the differentiation 
of Plasmodium species by analysing DNA fragments [46]. 
Another group evaluated the kinetics of protein interac-
tions on the example of binding kinetics of the PfEMP1 
protein var2CSA to different antibodies [47]. Here for 
the first time whole cell interactions of live parasites are 
investigated. This opens possibilities for malaria research 
not restricted to cytoadhesion studies. In addition, para-
site invasion and egress or intracellular growth could be 
investigated. QCM technology is a promising tool for 
research in basic science on parasite biology and para-
site interactions, and can also be applied for research on 
malaria vaccine and drug development.
Fig. 4 Example QCM signals and pictures obtained for CD36. Measurements were carried out on the two-channel sensor platform Fidget Type 1. a 
The samples (iRBCs and RBCs) were injected after achievement of a stable baseline followed by a short stop-flow interval. Adhesion of iRBCs (FCR3-
CD36) led to a decrease of the signal. The low frequency shift obtained with RBCs shows an unspecific drift due to the alterations in the viscosity 
of the fluid. Frequency shifts after 2.5 h (time frame indicated by vertical dotted lines) are −83 Hz for RBCs and −361 Hz for iRBCs indicating the 
attachment of iRBCs to CD36 on the quartz; b and c pictures of corresponding quartzes stained with DAPI after measurement in the QCM platform 
confirming the results. After injection of iRBCs it can be clearly seen in (b) that iRBCs bind to the attached C32 cell membranes expressing CD36 on 
the quartz. In contrast in (c), after the experiment with RBCs only very few RBCs are detected on the sensor surface and only cell membranes can be 
seen
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Conclusions
With the presented experiments QCM technology should 
be made accessible for malaria research. This technology 
enables the real-time detection of cytoadhesion of iRBCs 
under flow conditions without affecting viability of para-
sites. Head-to-head comparison to the standard assays 
in relevant experimental settings, for example in clinical 
settings within vaccine trials, are an obvious and impor-
tant next step that should be taken.
Additional files
Additional file 1. Example figure of frequency shifts after adding BSA. 
Incubations with varying concentrations of bovine serum albumin (BSA) 
(1 mg/ml, 2 %) showed no additional binding events, which would be 
seen by a continuous drop of frequency. Therefore, no additional unspe-
cific binding sites seem to be accessible.
Additional file 2. Example frequency shift after adding RBCs to a PLL-
coated quartz. For this experiment RBCs were added to a PLL-coated 
quartz. It can clearly be seen that cells attached rapidly (within minutes) 
to the quartz indicated by a very strong frequency shift (−3389 Hz). This 
shows that PLL is unspecifically sticky to cells and RBCs attach rapidly to it.
Additional file 3. Example frequency shift of a PLL-coated quartz after 
adding human serum (HSA) and subsequent addition of iRBCs (FCR3-
CSA). For this control experiment, PLL-coated quartzes were incubated 
with human serum so that proteins bound to PLL. Subsequent addition of 
iRBCs showed no binding events (no frequency shift) as they do not bind 
to proteins found in the serum. This controls shows that parasites do not 
bind unspecifically to any analyte that is coated to PLL.
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Fig. 5 Example QCM signals and pictures obtained for CSA via PLL. Measurements were carried out on the two-channel sensor platform Fidget 
Type 1. a Example curves show the frequency changes (∆f ) during the course of the experiment. After injection of the samples (iRBCs and RBCs), 
adhesion of iRBCs (FCR3-CSA) led to a decrease of the frequency signal, whereas the frequency signal for RBCs showed no signs of attachment. 
Frequency shifts after 2.5 h (time frame indicated by vertical dotted lines) are +47 Hz for RBCs and −63 Hz for iRBCs indicating attachment of iRBCs 
to the CSA; b and c pictures of the corresponding quartzes stained with DAPI after measurement in the QCM platform confirm the results. In b one 
can see the quartz after the experiment with iRBCs showing the stained nuclei of the attached iRBCs to the CSA on the quartz. In c the quartz after 
the experiment with RBCs can be seen, showing only very few RBCs on the sensor surface
Page 9 of 9Kömpf et al. Malar J  (2016) 15:317 
References
 1. Cooper MA, Singleton VT. A survey of the 2001 to 2005 quartz crystal 
microbalance biosensor literature: applications of acoustic physics to the 
analysis of biomolecular interactions. J Mol Recognit. 2007;20:154–84. 
doi:10.1002/jmr.826.
 2. Uttenthaler E, Schraml M, Mandel J, Drost S. Ultrasensitive quartz crystal 
microbalance sensors for detection of M13-Phages in liquids. Biosens 
Bioelectron. 2001;16:735–43.
 3. Speight RE, Cooper MA. A survey of the 2010 quartz crystal microbalance 
literature. J Mol Recognit. 2012;25:451–73. doi:10.1002/jmr.2209.
 4. Ward MD, Buttry DA. In situ interfacial mass detection with piezoelectric 
transducers. Science. 1990;249:1000–7. doi:10.1126/science.249.4972.1000.
 5. Becker B, Cooper MA. A survey of the 2006–2009 quartz crystal microbalance 
biosensor literature. J Mol Recognit. 2011;24:754–87. doi:10.1002/jmr.1117.
 6. Saitakis M, Gizeli E. Acoustic sensors as a biophysical tool for probing cell 
attachment and cell/surface interactions. Cell Mol Life Sci. 2012;69:357–
71. doi:10.1007/s00018-011-0854-8.
 7. WHO. World malaria report. Geneva: World Heath Organization; 2015.
 8. Baruch DI, Gormely JA, Ma C, Howard RJ, Pasloske BL. Plasmodium falcipa-
rum erythrocyte membrane protein 1 is a parasitized erythrocyte recep-
tor for adherence to CD36, thrombospondin, and intercellular adhesion 
molecule 1. Proc Natl Acad Sci USA. 1996;93:3497–502.
 9. Gardner JP, Pinches RA, Roberts DJ, Newbold CI. Variant antigens and 
endothelial receptor adhesion in Plasmodium falciparum. Proc Natl Acad 
Sci USA. 1996;93:3503–8.
 10. Nogueira PA, Wunderlich G, Pereira da Silva LH. Variant antigens of Plas-
modium falciparum encoded by the var multigenic family are multifunc-
tional macromolecules. Res Microbiol. 2001;152:141–7.
 11. Chulay JD, Ockenhouse CF. Host receptors for malaria-infected erythro-
cytes. Am J Trop Med Hyg. 1990;43(2 Pt 2):6–14.
 12. Beeson JG, Brown GV. Pathogenesis of Plasmodium falciparum malaria: 
the roles of parasite adhesion and antigenic variation. Cell Mol Life Sci. 
2002;59:258–71.
 13. Scherf A, Pouvelle B, Buffet PA, Gysin J. Molecular mechanisms of Plasmo-
dium falciparum placental adhesion. Cell Microbiol. 2001;3:125–31.
 14. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin 
sulfate A in the human placenta. Science. 1996;272:1502–4.
 15. Cojean S, Jafari-Guemouri S, Le Bras J, Durand R. Cytoadherence char-
acteristics to endothelial receptors ICAM-1 and CD36 of Plasmodium 
falciparum populations from severe and uncomplicated malaria cases. 
Parasite. 2008;15:163–9.
 16. Barnwell JW, Asch AS, Nachman RL, Yamaya M, Aikawa M, Ingravallo P. 
A human 88-kD membrane glycoprotein (CD36) functions in vitro as a 
receptor for a cytoadherence ligand on Plasmodium falciparum-infected 
erythrocytes. J Clin Invest. 1989;84:765–72. doi:10.1172/JCI114234.
 17. Udomsangpetch R, Taylor BJ, Looareesuwan S, White NJ, Elliott JF, Ho M. 
Receptor specificity of clinical Plasmodium falciparum isolates: nonadher-
ence to cell-bound E-selectin and vascular cell adhesion molecule-1. 
Blood. 1996;88:2754–60.
 18. Viebig NK, Levin E, Dechavanne S, Rogerson SJ, Gysin J, Smith JD, et al. 
Disruption of var2csa gene impairs placental malaria associated adhesion 
phenotype. PLoS One. 2007;2:e910. doi:10.1371/journal.pone.0000910.
 19. Fried M, Avril M, Chaturvedi R, Fernandez P, Lograsso J, Narum D, et al. Mul-
tilaboratory approach to preclinical evaluation of vaccine immunogens for 
placental malaria. Infect Immun. 2013;81:487–95. doi:10.1128/IAI.01106-12.
 20. Garner P, Gulmezoglu AM. Drugs for preventing malaria in preg-
nant women. Cochrane Database Syst Rev. 2006;4:CD000169. 
doi:10.1002/14651858.CD000169.pub2.
 21. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria 
in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64(1–2 
Suppl):28–35.
 22. Fusai T, Parzy D, Spillmann D, Eustacchio F, Pouvelle B, Lepolard C, et al. 
Characterisation of the chondroitin sulphate of Saimiri brain microvascu-
lar endothelial cells involved in Plasmodium falciparum cytoadhesion. Mol 
Biochem Parasitol. 2000;108:25–37.
 23. Turner L, Lavstsen T, Berger SS, Wang CW, Petersen JE, Avril M, et al. Severe 
malaria is associated with parasite binding to endothelial protein C 
receptor. Nature. 2013;498:502–5. doi:10.1038/nature12216.
 24. Paton D, Faragher B, Mustaffa KM, Szestak T, Barrett SD, Craig AG. Auto-
mated counting for Plasmodium falciparum cytoadherence experiments. 
Malar J. 2011;10:91. doi:10.1186/1475-2875-10-91.
 25. Hempel C, Boisen IM, Efunshile A, Kurtzhals JA, Staalso T. An automated 
method for determining the cytoadhesion of Plasmodium falciparum-
infected erythrocytes to immobilized cells. Malar J. 2015;14:112. 
doi:10.1186/s12936-015-0632-4.
 26. Carvalho BO, Lopes SC, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, 
et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J 
Infect Dis. 2010;202:638–47. doi:10.1086/654815.
 27. Raventos-Suarez C, Kaul DK, Macaluso F, Nagel RL. Membrane knobs are 
required for the microcirculatory obstruction induced by Plasmodium fal-
ciparum-infected erythrocytes. Proc Natl Acad Sci USA. 1985;82:3829–33.
 28. Nash GB, Cooke BM, Marsh K, Berendt A, Newbold C, Stuart J. Rheologi-
cal analysis of the adhesive interactions of red blood cells parasitized by 
Plasmodium falciparum. Blood. 1992;79:798–807.
 29. Herricks T, Seydel KB, Turner G, Molyneux M, Heyderman R, Taylor T, et al. 
A microfluidic system to study cytoadhesion of Plasmodium falciparum 
infected erythrocytes to primary brain microvascularendothelial cells. Lab 
Chip. 2011;11:2994–3000. doi:10.1039/c1lc20131j.
 30. Herricks T, Avril M, Janes J, Smith JD, Rathod PK. Clonal variants of Plasmo-
dium falciparum exhibit a narrow range of rolling velocities to host recep-
tor CD36 under dynamic flow conditions. Eukaryot Cell. 2013;12:1490–8. 
doi:10.1128/EC.00148-13.
 31. Cooke BM, Coppel RL. Cytoadhesion and falciparum malaria: going with 
the flow. Parasitol Today. 1995;11:282–7.
 32. Beeson JG, Rogerson SJ, Cooke BM, Reeder JC, Chai W, Lawson AM, et al. 
Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic 
acid in placental malaria. Nat Med. 2000;6:86–90. doi:10.1038/71582.
 33. Xu X, Efremov AK, Li A, Lai L, Dao M, Lim CT, et al. Probing the cytoad-
herence of malaria infected red blood cells under flow. PLoS One. 
2013;8:e64763. doi:10.1371/journal.pone.0064763.
 34. Phiri H, Montgomery J, Molyneux M, Craig A. Competitive endothelial 
adhesion between Plasmodium falciparum isolates under physiological 
flow conditions. Malar J. 2009;8:214. doi:10.1186/1475-2875-8-214.
 35. Adams Y, Rowe JA. The effect of anti-rosetting agents against malaria 
parasites under physiological flow conditions. PLoS One. 2013;8:e73999. 
doi:10.1371/journal.pone.0073999.
 36. Kalantari N, Ghaffari S, Bayani M. Plasmodium falciparum: adhesion 
phenotype of infected erythrocytes using classical and mini-column 
cytoadherence techniques. Iran J Parasitol. 2013;8:158–66.
 37. Trager W, Jensen JB. Human malaria parasites in continuous culture. Sci-
ence. 1976;193:673–5.
 38. Marsh K, Marsh VM, Brown J, Whittle HC, Greenwood BM. Plasmodium 
falciparum: the behavior of clinical isolates in an in vitro model of infected 
red blood cell sequestration. Exp Parasitol. 1988;65:202–8.
 39. Ljungström I, Perlmann H, Schlichtherle M, Scherf A, Wahlgren M. Meth-
ods in Malaria Research. 4th ed. Manassas: MR4/ATCC; 2004.
 40. Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson 
SJ. Plasmodium falciparum isolates from infected pregnant women and 
children are associated with distinct adhesive and antigenic properties. J 
Infect Dis. 1999;180:464–72. doi:10.1086/314899.
 41. Ribaut C, Berry A, Chevalley S, Reybier K, Morlais I, Parzy D, et al. 
Concentration and purification by magnetic separation of the eryth-
rocytic stages of all human Plasmodium species. Malar J. 2008;7:45. 
doi:10.1186/1475-2875-7-45.
 42. Sinn S, Muller L, Drechsel H, Wandel M, Northoff H, Ziemer G, et al. 
Platelet aggregation monitoring with a newly developed quartz crystal 
microbalance system as an alternative to optical platelet aggregometry. 
Analyst. 2010;135:2930–8. doi:10.1039/c0an00474j.
 43. Sinn S, Eichler M, Muller L, Bunger D, Groll J, Ziemer G, et al. NCO-sP(EO-
stat-PO) coatings on gold sensors—a QCM study of hemocompatibility. 
Sensors. 2011;11:5253–69. doi:10.3390/s110505253.
 44. Gehring FK. http://www.3t-analytik.de/. Accessed 31 July 2015.
 45. Voinova MV, Jonson M, Kasemo B. Missing mass effect in biosensor’s QCM 
applications. Biosens Bioelectron. 2002;17:835–41.
 46. Wangmaung N, Chomean S, Promptmas C, Mas-Oodi S, Tanyong D, Ittarat 
W. Silver quartz crystal microbalance for differential diagnosis of Plas-
modium falciparum and Plasmodium vivax in single and mixed infection. 
Biosens Bioelectron. 2014;62:295–301. doi:10.1016/j.bios.2014.06.052.
 47. Joergensen LM, Salanti A, Dobrilovic T, Barfod L, Hassenkam T, Theander 
TG, et al. The kinetics of antibody binding to Plasmodium falciparum 
VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on 
the membrane knobs. Malar J. 2010;9:100. doi:10.1186/1475-2875-9-100.
